Eventide Gilead C (ETCGX)

Fund Assets	2.92B
Expense Ratio	2.16%
Min. Investment	$1,000
Turnover	36.00%
Dividend (ttm)	0.64
Dividend Yield	1.28%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 13, 2024

Previous Close	50.21
YTD Return	15.60%
1-Year Return	21.54%
5-Year Return	27.80%
52-Week Low	34.85
52-Week High	50.21
Beta (5Y)	n/a
Holdings	71
Inception Date	Oct 28, 2009

About ETCGX

Eventide Gilead Fund Class C is an actively managed mid-cap growth mutual fund focused on long-term capital appreciation. The fund invests primarily in a broad range of equity securities across various market capitalizations, with no restrictions on geographic domicile, including U.S. and international companies. Its portfolio typically includes a diversified mix of holdings with historical emphasis on healthcare and technology sectors, reflecting its thematic focus on companies that align with values-driven investing and long-term stakeholder value creation. The fund aims to capture growth opportunities in mid-cap stocks while maintaining a balanced approach to risk, supported by a concentrated portfolio of around 60 to 90 holdings. Since its inception in 2009, Eventide Gilead Class C has established itself as a fund that blends ethical considerations with a pursuit of financial returns, representing a distinctive approach within the mid-cap growth category in the mutual fund market.

• Fund Family: Eventide Funds
• Category: Mid-Cap Growth
• Stock Exchange: NASDAQ
• Ticker Symbol: ETCGX
• Share Class: Class C
• Index: Russell MidCap Growth TR

Performance

ETCGX had a total return of 21.54% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.73%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
VMGRX	Vanguard	Vanguard Mid Cap Growth Inv	0.33%
FMDGX	Fidelity	Fidelity Mid Cap Growth Index	0.05%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
ETILX	Class I	1.16%
ETGLX	Class N	1.36%
ETAGX	Class A	1.41%

Top 10 Holdings

33.10% of assets

Name	Symbol	Weight
Verona Pharma plc	VRNA	6.41%
Guardant Health, Inc.	GH	4.29%
Toast, Inc.	TOST	3.74%
Xometry, Inc.	XMTR	3.65%
Trane Technologies plc	TT	2.98%
Mirum Pharmaceuticals, Inc.	MIRM	2.61%
iRhythm Technologies, Inc.	IRTC	2.56%
Vistra Corp.	VST	2.32%
Old Dominion Freight Line, Inc.	ODFL	2.28%
GE Vernova Inc.	GEV	2.27%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 13, 2024	$0.6441	Dec 16, 2024
Dec 15, 2022	$2.2812	Dec 16, 2022
Dec 16, 2021	$4.2652	Dec 17, 2021
Dec 17, 2020	$0.5114	Dec 17, 2020
Dec 17, 2019	$1.3176	Dec 17, 2019
Dec 18, 2018	$1.7132	Dec 18, 2018